Hongwei Cheng
Papers
1
Total Citations
18
H-Index
1
About
Hongwei Cheng is a pioneering researcher at the forefront of biomedical micro-robotics and targeted drug delivery systems. His work centers on developing intelligent, biocompatible micro-tools capable of navigating the complex physiological environments of the human body for minimally invasive therapies. Cheng’s most notable contribution is the creation of water-stable magnetic lipiodol micro-droplets, a novel formulation that serves as a miniaturized robotic tool for drug delivery. This breakthrough directly addresses critical clinical hurdles—including biocompatibility, precise control, and real-time tracking—that have long hindered the translation of microrobots from lab to clinic. His 2024 paper on this topic has already garnered 18 citations, reflecting its immediate impact on the field. By integrating magnetic responsiveness with a stable, biocompatible carrier, Cheng’s work offers a promising pathway toward intelligent, trackable, and controllable therapeutic agents. His research stands at the intersection of materials science, robotics, and nanomedicine, positioning him as a key innovator in the next generation of precision medicine technologies.
Research Focus
Key Achievements
Top Papers
- 1